(Q47988526)

English

Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

0 references

1 reference

based on heuristic

inferred from title

author name string

Arikan C

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Bahceciler NN

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Deniz G

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Akdis M

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Akkoc T

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Akdis CA

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Barlan IB

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

34

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

398-405

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Atopic disorders: a vaccine around the corner?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Immunoprophylaxis of atopy: light at the end of the tunnel?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01869.X

21 January 2018

Identifiers

10.1111/J.1365-2222.2004.01869.X

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15005733

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47988526&oldid=2180688504"